1. Home
  2. YAAS vs SER Comparison

YAAS vs SER Comparison

Compare YAAS & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youxin Technology Ltd

YAAS

Youxin Technology Ltd

HOLD

Current Price

$0.75

Market Cap

21.2M

Sector

Technology

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.17

Market Cap

19.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YAAS
SER
Founded
2018
2017
Country
China
United States
Employees
22
13
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
19.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
YAAS
SER
Price
$0.75
$2.17
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
173.3K
60.9K
Earning Date
01-29-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$1.22
52 Week High
$4.64
$7.92

Technical Indicators

Market Signals
Indicator
YAAS
SER
Relative Strength Index (RSI) 45.52 60.13
Support Level $0.71 $1.69
Resistance Level $1.05 $3.25
Average True Range (ATR) 0.12 0.19
MACD 0.00 0.01
Stochastic Oscillator 30.56 93.50

Price Performance

Historical Comparison
YAAS
SER

About YAAS Youxin Technology Ltd

Youxin Technology Ltd is a SaaS and PaaS provider committed to helping retail enterprises digitally transform their businesses to develop, use and control business applications without the need to purchase complex IT infrastructure. The company leverages the technologies used to develop its PaaS platform to standardize customized customer relationship management, or CRM, services to its clients that seamlessly connect all levels of the retail chain from management teams to customers. Its products give its retail clients a comprehensive view of their business operations in real-time on multiple interfaces, allowing them to make critical business decisions anytime and anywhere. Geographically operates in PRC, Hong Kong, and Cayman Island.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: